Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 10
Corrigendum
Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,141 | Dovepress* | 4,929+ | 1,236 | 6,165 | |
| PubMed Central* | 212 | 108 | 320 | ||
| Totals | 5,141 | 1,344 | 6,485 | ||
| *Since 16 July 2018 | |||||
View citations on PubMed Central and Google Scholar